Reduced MCT1 results in neurons being at a heightened risk to age-related disorders including ALS [34] and it has been shown that MCT1 is downregulated in ALS [4,13] and oligodendrocytes have a reduced capacity to traffic lactate through MCT1 in ALS [9]. This evidence concerns the gene SLC16A1 and amyotrophic lateral sclerosis.